MLP Group Valuation
Is MLG undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MLG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MLG (PLN84.2) is trading above our estimate of fair value (PLN79.16)
Significantly Below Fair Value: MLG is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MLG?
Other financial metrics that can be useful for relative valuation.
| What is MLG's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | zł2.02b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 10.7x |
| Enterprise Value/EBITDA | 21.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does MLG's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.9x | ||
DVL Develia | 1.9x | 8.3% | zł3.0b |
CFI CFI Holding | 2.7x | n/a | zł624.4m |
CAV Cavatina Holding Spólka Akcyjna | 2.5x | n/a | zł383.9m |
EFK Korporacja Gospodarcza efekt | 0.6x | n/a | zł37.0m |
MLG MLP Group | 5.6x | 20.1% | zł2.0b |
Price-To-Sales vs Peers: MLG is expensive based on its Price-To-Sales Ratio (5.6x) compared to the peer average (1.9x).
Price to Earnings Ratio vs Industry
How does MLG's PE Ratio compare vs other companies in the PL Real Estate Industry?
Price-To-Sales vs Industry: MLG is expensive based on its Price-To-Sales Ratio (5.6x) compared to the Polish Real Estate industry average (1.9x).
Price to Sales Ratio vs Fair Ratio
What is MLG's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 5.6x |
| Fair PS Ratio | 4.9x |
Price-To-Sales vs Fair Ratio: MLG is expensive based on its Price-To-Sales Ratio (5.6x) compared to the estimated Fair Price-To-Sales Ratio (4.9x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | zł84.20 | zł116.38 +38.2% | 1.2% | zł117.75 | zł115.00 | n/a | 2 |
| May ’25 | zł80.00 | zł116.38 +45.5% | 1.2% | zł117.75 | zł115.00 | n/a | 2 |
| Apr ’25 | zł76.00 | zł116.38 +53.1% | 1.2% | zł117.75 | zł115.00 | n/a | 2 |
| Mar ’25 | zł78.60 | zł112.67 +43.3% | 2.1% | zł115.00 | zł110.33 | n/a | 2 |
| Feb ’25 | zł70.20 | zł112.67 +60.5% | 2.1% | zł115.00 | zł110.33 | n/a | 2 |
| Jan ’25 | zł71.00 | zł112.67 +58.7% | 2.1% | zł115.00 | zł110.33 | n/a | 2 |
| Dec ’24 | zł78.40 | zł112.67 +43.7% | 2.1% | zł115.00 | zł110.33 | n/a | 2 |
| Nov ’24 | zł75.80 | zł112.67 +48.6% | 2.1% | zł115.00 | zł110.33 | n/a | 2 |
| Oct ’24 | zł82.00 | zł112.67 +37.4% | 2.1% | zł115.00 | zł110.33 | n/a | 2 |
| Sep ’24 | zł85.00 | zł106.67 +25.5% | 3.4% | zł110.33 | zł103.00 | n/a | 2 |
| Aug ’24 | zł85.80 | zł106.67 +24.3% | 3.4% | zł110.33 | zł103.00 | n/a | 2 |
| Jul ’24 | zł84.80 | zł106.67 +25.8% | 3.4% | zł110.33 | zł103.00 | n/a | 2 |
| Jun ’24 | zł84.80 | zł106.67 +25.8% | 3.4% | zł110.33 | zł103.00 | n/a | 2 |
| May ’24 | zł83.20 | zł98.38 +18.2% | 4.7% | zł103.00 | zł93.75 | zł80.00 | 2 |
| Apr ’24 | zł76.00 | zł95.88 +26.2% | 2.2% | zł98.00 | zł93.75 | zł76.00 | 2 |
| Mar ’24 | zł75.00 | zł95.88 +27.8% | 2.2% | zł98.00 | zł93.75 | zł78.60 | 2 |
| Feb ’24 | zł78.60 | zł95.88 +22.0% | 2.2% | zł98.00 | zł93.75 | zł70.20 | 2 |
| Jan ’24 | zł76.00 | zł95.88 +26.2% | 2.2% | zł98.00 | zł93.75 | zł71.00 | 2 |
| Dec ’23 | zł74.20 | zł95.88 +29.2% | 2.2% | zł98.00 | zł93.75 | zł78.40 | 2 |
| Nov ’23 | zł70.00 | zł95.88 +37.0% | 2.2% | zł98.00 | zł93.75 | zł75.80 | 2 |
| Oct ’23 | zł71.60 | zł95.88 +33.9% | 2.2% | zł98.00 | zł93.75 | zł82.00 | 2 |
| Sep ’23 | zł71.00 | zł95.88 +35.0% | 2.2% | zł98.00 | zł93.75 | zł85.00 | 2 |
| Aug ’23 | zł60.80 | zł95.38 +56.9% | 1.7% | zł97.00 | zł93.75 | zł85.80 | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.